Citation 148242

JIA,RR: TAN,NH: MU,Q: LI,CM: QIU,MH: LIU,JK:. (2000). THE EFFECT OF SOME NATURAL PRODUCTS ON THE FIBRINOLYTIC SYSTEM.. 22(4)

Citation Details

Title	THE EFFECT OF SOME NATURAL PRODUCTS ON THE FIBRINOLYTIC SYSTEM.
Authors	JIA,RR: TAN,NH: MU,Q: LI,CM: QIU,MH: LIU,JK:
Year	2000
Volume	22
Issue	4

Summary

Year: 2000

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	THROMBIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ROLIN B,EPOXY:	WEAK ACTIVITY
2	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ROLIN B,EPOXY:	INACTIVE
3	PLASMINOGEN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ROLIN B,EPOXY:	WEAK ACTIVITY
4	PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ROLIN B,EPOXY:	INACTIVE
5	THROMBIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHERIMOLIN 2	WEAK ACTIVITY
6	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHERIMOLIN 2	INACTIVE
7	PLASMINOGEN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHERIMOLIN 2	STRONG ACTIVITY
8	PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHERIMOLIN 2	WEAK ACTIVITY
9	THROMBIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMNACANTHAL	INACTIVE
10	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMNACANTHAL	INACTIVE
11	PLASMINOGEN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMNACANTHAL	STRONG ACTIVITY
12	PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMNACANTHAL	ACTIVE
13	THROMBIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MURICATIN C	INACTIVE
14	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MURICATIN C	INACTIVE
15	PLASMINOGEN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MURICATIN C	INACTIVE
16	PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MURICATIN C	WEAK ACTIVITY
17	THROMBIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORINDONE	INACTIVE
18	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORINDONE	ACTIVE
19	PLASMINOGEN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORINDONE	STRONG ACTIVITY
20	PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORINDONE	WEAK ACTIVITY
21	THROMBIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CLERODA-4(18)-CIS-13(14)-DIEN-15-16-OLIDE,16-ALPHA-HYDROXY:	STRONG ACTIVITY
22	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CLERODA-4(18)-CIS-13(14)-DIEN-15-16-OLIDE,16-ALPHA-HYDROXY:	ACTIVE
23	PLASMINOGEN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CLERODA-4(18)-CIS-13(14)-DIEN-15-16-OLIDE,16-ALPHA-HYDROXY:	STRONG ACTIVITY
24	PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CLERODA-4(18)-CIS-13(14)-DIEN-15-16-OLIDE,16-ALPHA-HYDROXY:	WEAK ACTIVITY
25	THROMBIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEDERAGENIN	ACTIVE
26	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEDERAGENIN	WEAK ACTIVITY
27	PLASMINOGEN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEDERAGENIN	STRONG ACTIVITY
28	PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEDERAGENIN	INACTIVE
29	THROMBIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OCTADEC-9-YN-OIC ACID	STRONG ACTIVITY
30	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OCTADEC-9-YN-OIC ACID	WEAK ACTIVITY
31	PLASMINOGEN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OCTADEC-9-YN-OIC ACID	STRONG ACTIVITY
32	PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OCTADEC-9-YN-OIC ACID	STRONG ACTIVITY

Citation 148242

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1